Why the study?
Cardiovascular autonomic neuropathy impairs cardiovascular autonomic control in diabetes, and this study aimed to investigate the relationship between glycemic variability and cardiovascular autonomic neuropathy in pediatric patients with type 1 DM.
Is glycemic variability associated with cardiovascular autonomic neuropathy in pediatric patients with type 1 diabetes mellitus?
Is glycemic variability associated with cardiovascular autonomic neuropathy in pediatric patients with type 1 diabetes mellitus?
In pediatric patients with type 1 diabetes, higher glycemic variability (lower time in range and higher time above range) is significantly associated with definitive cardiovascular autonomic neuropathy.
Answers are grounded in this paper and cite their sources.
Glycemic variability may signal CAN risk in pediatric T1DM; leaves open whether targeting variability prevents neuropathy.
Objective: Objective: Cardiovascular autonomic neuropathy (CAN) is defined as the impairment of cardiovascular autonomic control in patients with diabetes mellitus (DM) after excluding other causes. This study aims to investigate the relationship between glycemic variability and CAN in pediatric patients with type 1 DM Material and Methods: The study population consisted of children aged 8-18 who were being followed up with the diagnosis of type 1 DM. The diagnosis of CAN was made based on the heart rate variability indices and the results of the cardiovascular reflex tests.. Results: The study included 21 pediatric patients with type 1 diabetes mellitus (DM), consisting of 6 males and 15 females, with a median age of 13.94 years. Among them, 5 (23.8%) had early involvement, and 4 (19%) had definitive cardiovascular autonomic neuropathy (CAN). Patients with definitive CAN were significantly older and had a longer disease duration than those without CAN (p<0.05). Additionally, patients with definitive CAN had significantly higher hemoglobin A1c (HbA1c) levels (p<0.05). The time in the target blood glucose range (TIR) was significantly lower, while the time above the target blood glucose range (TAR) was significantly higher in patients with definitive CAN than in other patients (p<0.05). The standard deviation (SD) was also higher in patients with definitive CAN, but not significantly so (p>0.05). Conclusion: The study's findings indicated that TIR, which is one of the glycemic variability parameters, was significantly lower and TAR was considerably higher in children with definitive CAN, and SD was higher, albeit not significantly, in children with definitive CAN. Nevertheless, large-scale, prospective cohort studies are needed to fully elucidate the relationship between CAN and glycemic variability in pediatric type 1 DM patients.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: